Fatty Liver News and Research

Latest Fatty Liver News and Research

UVA researchers discover a key trigger for non-alcoholic fatty liver disease

University of Virginia School of Medicine researchers have discovered a key trigger for non-alcoholic fatty liver disease, a mysterious condition that causes fat to build up in the liver for no clear reason.

9 Feb 2023

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Biochemist Jon Jacobs has analyzed the blood of patients with diseases and conditions such as Ebola, cancer, tuberculosis, hepatitis, diabetes, Lyme disease, brain injury and influenza.

9 Feb 2023

Researchers find possible genetic basis and mouse model for nonalcoholic steatohepatitis

A mutant or damaged gene may be a cause of a severe, mysterious form of nonalcoholic fatty liver disease, University of Illinois Urbana-Champaign researchers have found.

9 Feb 2023

Exercise can be used as a treatment for nonalcoholic fatty liver disease

The 150 minutes of moderate to intense aerobic activity per week that is recommended by the U.S. Department of Health and Human Services can significantly reduce liver fat, according to new research by Penn State College of Medicine researchers.

9 Feb 2023

Exercise can lead to meaningful reductions in liver fat for patients with NAFLD, research confirms

Penn State College of Medicine researchers confirmed exercise can lead to meaningful reductions in liver fat for patients with nonalcoholic fatty liver disease.

8 Feb 2023

Patient's satisfaction with physician associated with completion of bariatric surgery

Patients' satisfaction with their physicians may influence their decisions to undergo bariatric surgery, according to a multicenter study involving UT Southwestern and the UTHealth School of Public Health published in JAMA Network Open.

8 Feb 2023

Researchers highlight the dysregulation of hepatokines in people with NAFLD

Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases.

7 Feb 2023

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the publication of a peer-reviewed study in the Journal of Clinical and Translational Hepatology, “Breath Biopsy to identify exhaled volatile organic compounds as biomarkers for liver cirrhosis detection”.

From Owlstone Medical Ltd 7 Feb 2023

Gut hormone receptor polyagonists show promise for obesity and diabetes

A new paper in the Journal of Clinical Investigation describes drugs that could help lose weight and manage type 2 diabetes mellitus (T2DM).

6 Feb 2023

Study reveals a vulnerability of macrophages that contributes to chronic inflammatory diseases

Macrophages are cells of the immune system that, in addition to playing an essential role in the early response to microbial infection, also regulate tissue function and inflammation.

3 Feb 2023

Study identifies a drug candidate for the treatment of fatty liver disease

There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases.

3 Feb 2023

Knowing your cholesterol level can be a crucial factor in overall health

On a top 10 list of things to do, getting your cholesterol level checked likely doesn't make the cut – but no matter your age, knowing your numbers can be a crucial factor in overall health.

2 Feb 2023

Liver cancer treatment can place significant financial burden on patients, analysis shows

Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.

30 Jan 2023

Keto diet as a PCOS treatment

A recent study explores the role of the ketogenic diet in the treatment of polycystic ovarian syndrome.

29 Jan 2023

Genetically increasing omega-3 fatty acid production improves glucose balance in obese mice

A new study from researchers at Laval University in Quebec, Canada, shows that genetically increasing omega-3 fatty acid production, without direct gut microbiota contact, improves the balance of insulin and glucagon (glucose balance) in obese mice.

25 Jan 2023

Consuming soy flour rich in protein B-conglycinin could reduce LDL cholesterol levels

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study.

23 Jan 2023

What is the association between fast-food intake and liver steatosis?

Researchers quantified the adverse effects of fast-food intake on liver steatosis in new research.

18 Jan 2023

American Academy of Pediatrics releases the first clinical practice guideline for evaluating and treating childhood obesity

A recent news article published by the American Academy of Pediatrics (AAP) discussed the first clinical practice guideline released by the AAP to effectively and safely evaluate and treat pediatric obesity in children and adolescents.

13 Jan 2023

Effectiveness of slow eating intervention tested in overweight and obese women

A recent Eating Behaviors study has aimed to develop and test the effectiveness of a 5-week slow-eating intervention in obese women.

11 Jan 2023

Eating fast food associated with nonalcoholic fatty liver disease

The new year has begun, and with it, resolutions for change. A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology gives people extra motivation to reduce fast-food consumption.

10 Jan 2023

Fatty Liver News and Research

Latest Fatty Liver News and Research

UVA researchers discover a key trigger for non-alcoholic fatty liver disease

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Researchers find possible genetic basis and mouse model for nonalcoholic steatohepatitis

Exercise can be used as a treatment for nonalcoholic fatty liver disease

Exercise can lead to meaningful reductions in liver fat for patients with NAFLD, research confirms

Patient's satisfaction with physician associated with completion of bariatric surgery

Researchers highlight the dysregulation of hepatokines in people with NAFLD

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

Gut hormone receptor polyagonists show promise for obesity and diabetes

Study reveals a vulnerability of macrophages that contributes to chronic inflammatory diseases

Study identifies a drug candidate for the treatment of fatty liver disease

Knowing your cholesterol level can be a crucial factor in overall health

Liver cancer treatment can place significant financial burden on patients, analysis shows

Keto diet as a PCOS treatment

Genetically increasing omega-3 fatty acid production improves glucose balance in obese mice

Consuming soy flour rich in protein B-conglycinin could reduce LDL cholesterol levels

What is the association between fast-food intake and liver steatosis?

American Academy of Pediatrics releases the first clinical practice guideline for evaluating and treating childhood obesity

Effectiveness of slow eating intervention tested in overweight and obese women

Eating fast food associated with nonalcoholic fatty liver disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Fatty Liver News and Research

Latest Fatty Liver News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in